Re: GERN telomerase vaccine in prostate cancer
Thanks, Urche, for your cogent observations. I do not consider GERN’s vaccine program a threat to anything DNDN is doing.
>>It is interesting to compare the GERN PR spin vs the actual abstract…<<
Yes, GERN is a master of spin --enough spin to keep me from being seriously interested in them as an investment. It may be my loss, but so be it.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”